Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101074209A details a novel Cu-catalyzed route for (Z)-3-(bromomethylene)isoindolin-1-one. Discover cost-effective synthesis and scalable supply chain solutions.
Advanced process for Nebivolol intermediates using B-alkyl Suzuki cyclization. Enhances purity and supply chain reliability for cardiovascular API manufacturing.
Novel one-step synthesis of pyrazolo[4,3-c]quinoline derivatives using triflic acid. High yield, metal-free process for pharma intermediates.
Patent CN113072456A details a novel copper-catalyzed asymmetric difluoromethylation for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN113461589A details a novel one-step asymmetric Friedel-Crafts reaction yielding high-purity chiral indoleamines with significant cost reduction potential.
Patent CN103087028A details a robust Grignard-Suzuki route for Nebivolol intermediates, offering cost reduction and scalable chiral chroman manufacturing for global supply chains.
Novel patent CN115925616B offers high purity lercanidipine via green catalytic routes ensuring supply chain stability and reduced toxic reagent usage for global buyers
Patent CN102212060A details a novel aminolysis route for Lafutidine, eliminating dihydro impurities and offering significant cost reduction in pharmaceutical manufacturing.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Patent CN101792400A details a high-yield four-step route for Agomelatine, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel copper-catalyzed method offers high yield and safety for pharmaceutical intermediates manufacturing supply chain ensuring reliable global sourcing and substantial cost efficiency.
Patent CN1931857A reveals a scalable permanganate oxidation route for Losartan 5-carboxylate (EXP-3174), offering high purity and eliminating chromatography for cost-effective API manufacturing.
Patent CN104529935A enables high-purity synthesis with reduced steps. Delivers significant cost reduction and supply chain reliability for global buyers.
Patent CN103073492A details a green Ru-catalyzed transfer hydrogenation for Montelukast intermediates, offering significant cost reduction and supply chain reliability.
Advanced preparation of cyclohexene carboxylates for neuraminidase inhibitors. Optimized route offers cost reduction and scalable manufacturing for API intermediates.
Patent CN103360458B details a novel Abiraterone synthesis route avoiding palladium. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel one-step secnidazole preparation improves yield to 60% and reduces solvent use for cost effective pharmaceutical manufacturing supply chains.
Patent CN106749447A reveals a stable ketal protection route for epirubicin synthesis, offering high purity and cost reduction in API manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN106674264A reveals high-yield route for pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing costs significantly.